Company Overview
- Headquarters
- 1500 1st Ave N, Birmingham AL
- Website
- alveolusbio.com
- Employees
- 7
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is Alveolus Bio
Alveolus Bio is a privately held company based in Birmingham, Alabama, with a team of seven employees. Alveolus Bio focuses on developing innovative, FDA-approved therapeutics for a range of lung diseases. Their current pipeline includes preclinical stage live biotherapeutics targeting Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), and Non-Cystic Fibrosis Bronchiectasis (NCFBE). Their approach utilizes inhaled delivery, allowing for targeted treatment of the lungs' distal regions. This method bypasses first-pass metabolism, potentially enhancing drug efficacy while minimizing adverse effects compared to traditional treatments. Visit alveolusbio.com for more information.
Company Leadership
Alveolus Bio Industry Tags
Companies Similar to Alveolus Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Alveolus Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |